REG - Induction Healthcare - Purchase of Shares by Directors
12/04/2022 07:00
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220412:nRSL0333Ia&default-theme=true
RNS Number : 0333I Induction Healthcare Group PLC 12 April 2022
Induction Healthcare Group PLC
("Induction", the "Company", or the "Group")
Purchase of Shares by Directors
Induction Healthcare (AIM: INHC), a leading digital health platform driving
transformation of healthcare systems worldwide, announces the following
Director purchases of, in aggregate, 364,589 ordinary shares in the Company:
Name Position Number of Ordinary Shares Purchased Price per Ordinary Share Resultant Shareholding Percentage of Issued Share Capital
James Balmain Chief Executive Officer 7,300 54.0987p 706,573 0.77%
Guy Mitchell Chief Financial Officer 9,200 54.0987p 9,200 0.01%
Hugo Stephenson* Group Executive Director 100,000 54.0987p 2,226,273 2.42%
Leslie-Ann Reed Non-Executive Director 57,100 52.5p 57,100 0.06%
Andy Williams Non-Executive Director 190,989 52.5p 610,484 0.66%
* Dr Stephenson's shareholding shown above excludes the 7,152,600 ordinary
shares which are held by Blue Muse Investments Pty Ltd, as trustee of The Blue
Muse Trust (a trust which is controlled by Hugo Stephenson's mother and of
which close relatives including his children and friends of Hugo Stephenson
are beneficiaries).
ENQUIRIES
Induction Via Walbrook PR Ltd: induction@walbrookpr.com
(mailto:induction@walbrookpr.com)
James Balmain, Chief Executive Officer
Guy Mitchell, Chief Financial Officer
Singer Capital Markets (Nominated Adviser and Broker) +44 (0)20 7496 3000
Philip Davies / Kailey Aliyar
Walbrook PR Ltd induction@walbrookpr.com (mailto:induction@walbrookpr.com)
Paul McManus / Alice Woodings Mob: +44(0)7980 541 893 / +44 (0)7407 804 654
About Induction - www.inductionhealthcare.com
(http://www.inductionhealthcare.com)
Induction (AIM: INHC) Induction delivers a suite of software solutions through
a single integrated platform that transforms care delivery. Our system-wide
applications help healthcare providers and administrators to deliver care at
any stage remotely as well as face-to-face - enabling a more flexible,
efficient and positive experience for the communities they serve. Purpose
built for integration with leading Electronic Medical Record (EMR) platforms,
our products offer immediate stand-alone value that becomes even greater when
integrated with pre-existing systems.
Used at scale by national and regional healthcare systems, as well non-health
government services, our applications are relied upon by hundreds of thousands
of clinicians and millions of patients across almost every hospital in the
British Isles.
The information set out below is provided in accordance with the requirements
of Article 19(3) of the EU Market Abuse Regulation No 596/2014
1. Details of the person discharging managerial responsibilities / person closely
associated
a. Name James Balmain
2. Reason for the notification
a. Position/status Chief Executive Officer
a. Initial notification /Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a. Name Induction Healthcare Group plc
b. LEI 213800RY96GCZQW5TP19
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a. Description of the Financial instrument, type of instrument Ordinary shares of 0.5 pence each
Identification code
GB00BJ0M3545
b. Nature of the transaction Purchase of Ordinary Shares
c. Price(s) and volume(s) 54.0987 pence
7,300 Ordinary Shares
d. Aggregated information N/A
·Aggregated volume
·Price
e. Date of the transaction 11 April 2022
f. Place of the transaction London Stock Exchange
1. Details of the person discharging managerial responsibilities / person closely
associated
a. Name Guy Mitchell
2. Reason for the notification
a. Position/status Chief Financial Officer
a. Initial notification /Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a. Name Induction Healthcare Group plc
b. LEI 213800RY96GCZQW5TP19
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a. Description of the Financial instrument, type of instrument Ordinary shares of 0.5 pence each
Identification code
GB00BJ0M3545
b. Nature of the transaction Purchase of Ordinary Shares
c. Price(s) and volume(s) 54.0987 pence
9,200 Ordinary Shares
d. Aggregated information N/A
·Aggregated volume
·Price
e. Date of the transaction 11 April 2022
f. Place of the transaction London Stock Exchange
1. Details of the person discharging managerial responsibilities / person closely
associated
a. Name Hugo Stephenson
2. Reason for the notification
a. Position/status Group Executive Director
a. Initial notification /Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a. Name Induction Healthcare Group plc
b. LEI 213800RY96GCZQW5TP19
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a. Description of the Financial instrument, type of instrument Ordinary shares of 0.5 pence each
Identification code
GB00BJ0M3545
b. Nature of the transaction Purchase of Ordinary Shares
c. Price(s) and volume(s) 54.0987 pence
100,000 Ordinary Shares
d. Aggregated information N/A
·Aggregated volume
·Price
e. Date of the transaction 11 April 2022
f. Place of the transaction London Stock Exchange
1. Details of the person discharging managerial responsibilities / person closely
associated
a. Name Leslie-Ann Reed
2. Reason for the notification
a. Position/status Non-Executive Director
a. Initial notification /Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a. Name Induction Healthcare Group plc
b. LEI 213800RY96GCZQW5TP19
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a. Description of the Financial instrument, type of instrument Ordinary shares of 0.5 pence each
Identification code
GB00BJ0M3545
b. Nature of the transaction Purchase of Ordinary Shares
c. Price(s) and volume(s) 52.5 pence
57,100 Ordinary Shares
d. Aggregated information N/A
·Aggregated volume
·Price
e. Date of the transaction 11 April 2022
f. Place of the transaction London Stock Exchange
1. Details of the person discharging managerial responsibilities / person closely
associated
a. Name Andy Williams
2. Reason for the notification
a. Position/status Non-Executive Director
a. Initial notification /Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a. Name Induction Healthcare Group plc
b. LEI 213800RY96GCZQW5TP19
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a. Description of the Financial instrument, type of instrument Ordinary shares of 0.5 pence each
Identification code
GB00BJ0M3545
b. Nature of the transaction Purchase of Ordinary Shares
c. Price(s) and volume(s) 52.5 pence
190,989 Ordinary Shares
d. Aggregated information N/A
·Aggregated volume
·Price
e. Date of the transaction 11 April 2022
f. Place of the transaction London Stock Exchange
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHUAAKRUUUSAARRecent news on Induction Healthcare
See all newsREG - Induction Healthcare - Block listing Interim Review
AnnouncementREG - Induction Healthcare - Half-year Report
AnnouncementREG - Induction Healthcare - Update on NHS National Portals Contracts
AnnouncementREG - Induction Healthcare - Result of AGM
AnnouncementREG - Induction Healthcare - Block listing Interim Review
Announcement